2 chapters across the catalog
The Defense Threat Reduction Agency (DTRA) is identified as a major source of funding for biopharmaceutical companies. The agency's mission is to safeguard the U.S. against weapons of mass destruction, but it is characterized here as a vehicle for awarding massive, multi-billion dollar government contracts.
Obama Avian Flu Legislation and Stock Investments
Unverified reports suggest that as a Senator in 2005, Barack Obama invested between $50,000 and $100,000 in AVI BioPharma shortly before introducing the Avian Act (S. 969). The legislation pushed for increased federal spending to fight avian flu, raising questions about potential conflicts of interest regarding his personal portfolio.
